Winter Zhang Selected Research

Glutaminase

1/2019	LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS-Mutant Lung Adenocarcinoma.
1/2017	Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Winter Zhang Research Topics

Disease

4	Neoplasms (Cancer) 12/2023 - 01/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2017
1	Adenocarcinoma of Lung 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

2	Glutamine (L-Glutamine)FDA Link 01/2019 - 01/2017
2	GlutaminaseIBA 01/2019 - 01/2017
1	Adenosine (Adenocard)FDA LinkGeneric 12/2023
1	Adenosine Monophosphate (AMP)IBA 12/2023
1	CB-1158IBA 12/2017
1	Gemcitabine FDA Link 12/2017
1	ArginaseIBA 12/2017
1	Arginine (L-Arginine)FDA Link 12/2017
1	InterferonsIBA 12/2017
1	Proteins (Proteins, Gene)FDA Link 12/2017
1	CytokinesIBA 12/2017
1	CB-839IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2017

Therapy/Procedure

2	Immunotherapy 12/2023 - 12/2017
1	Oral Administration 12/2023
1	Drug Therapy (Chemotherapy) 12/2017
1	Therapeutics 12/2017